Literature DB >> 33523744

Admission Practices And Cost Of Care For Opioid Use Disorder At Residential Addiction Treatment Programs In The US.

Tamara Beetham1, Brendan Saloner2, Marema Gaye3, Sarah E Wakeman4, Richard G Frank5, Michael Lawrence Barnett6.   

Abstract

The use of acute, short-term residential care for opioid use disorder has grown rapidly, with policy makers advocating to increase the availability of "treatment beds." However, there are concerns about high costs and misleading recruitment practices. We conducted an audit survey of 613 residential programs nationally, posing as uninsured cash-paying individuals using heroin and seeking addiction treatment. One-third of callers were offered admission before clinical evaluation, usually within one day. Most programs required up-front payments, with for-profit programs charging more than twice as much ($17,434) as nonprofits ($5,712). Recruitment techniques (for example, offering paid transportation) were used frequently by for-profit, but not nonprofit, programs. Practices including admission offers during the call, high up-front payments, and recruitment techniques were common even among programs with third-party accreditation and state licenses. These findings raise concerns that residential programs, including accredited and licensed ones, may be admitting a clinically and financially vulnerable population for costly treatment without assessing appropriateness for other care settings.

Entities:  

Mesh:

Year:  2021        PMID: 33523744      PMCID: PMC8638362          DOI: 10.1377/hlthaff.2020.00378

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  7 in total

1.  Loss of tolerance and overdose mortality after inpatient opiate detoxification: follow up study.

Authors:  John Strang; Jim McCambridge; David Best; Tracy Beswick; Jenny Bearn; Sian Rees; Michael Gossop
Journal:  BMJ       Date:  2003-05-03

2.  Taking the mystery out of "mystery shopper" studies.

Authors:  Karin Rhodes
Journal:  N Engl J Med       Date:  2011-07-27       Impact factor: 91.245

3.  Access to Office-Based Buprenorphine Treatment in Areas With High Rates of Opioid-Related Mortality: An Audit Study.

Authors:  Tamara Beetham; Brendan Saloner; Sarah E Wakeman; Marema Gaye; Michael L Barnett
Journal:  Ann Intern Med       Date:  2019-06-04       Impact factor: 25.391

4.  Comparative Effectiveness of Different Treatment Pathways for Opioid Use Disorder.

Authors:  Sarah E Wakeman; Marc R Larochelle; Omid Ameli; Christine E Chaisson; Jeffrey Thomas McPheeters; William H Crown; Francisca Azocar; Darshak M Sanghavi
Journal:  JAMA Netw Open       Date:  2020-02-05

5.  Prevalence, Treatment, And Unmet Treatment Needs Of US Adults With Mental Health And Substance Use Disorders.

Authors:  Beth Han; Wilson M Compton; Carlos Blanco; Lisa J Colpe
Journal:  Health Aff (Millwood)       Date:  2017-10-01       Impact factor: 6.301

6.  Overdose after detoxification: a prospective study.

Authors:  James D Wines; Richard Saitz; Nicholas J Horton; Christine Lloyd-Travaglini; Jeffrey H Samet
Journal:  Drug Alcohol Depend       Date:  2007-02-05       Impact factor: 4.492

7.  Barriers to accessing treatment for pregnant women with opioid use disorder in Appalachian states.

Authors:  Stephen W Patrick; Melinda B Buntin; Peter R Martin; Theresa A Scott; William Dupont; Michael Richards; William O Cooper
Journal:  Subst Abus       Date:  2018-10-09       Impact factor: 3.984

  7 in total
  4 in total

1.  Association of facility characteristics and substance use disorder outcomes at discharge from residential treatment.

Authors:  Jennifer Miles; Amy Mericle; Grant Ritter; Sharon Reif
Journal:  J Subst Abuse Treat       Date:  2021-11-15

2.  Detecting fraud, waste, and abuse in substance use disorder treatment.

Authors:  Melissa M Garrido; David K Jones; Alexander Woodruff; Kiersten Strombotne; Sivagaminathan Palani; Sarah Zahakos; Michael Adelberg; Steven D Pizer; Austin B Frakt
Journal:  Health Serv Res       Date:  2022-08-19       Impact factor: 3.734

3.  Services Available at United States Addiction Treatment Facilities That Offer Medications versus Behavioral Treatment Only: A Cross-Sectional, Observational Analysis.

Authors:  Andrea Weber; Benjamin Miskle; Alison Lynch; Stephan Arndt; Laura Acion
Journal:  Subst Abuse Rehabil       Date:  2022-09-07

4.  Development of an unannounced standardized patient protocol to evaluate opioid use disorder treatment in pregnancy for American Indian and rural communities.

Authors:  A Taylor Kelley; Marcela C Smid; Jacob D Baylis; Elizabeth Charron; Amy E Binns-Calvey; Shayla Archer; Saul J Weiner; Lori Jo Begaye; Gerald Cochran
Journal:  Addict Sci Clin Pract       Date:  2021-06-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.